The Leader of the House leapt to the defence of the Queen amid the fallout from Harry and Meghan's Oprah Winfrey interview
The Leader of the House leapt to the defence of the Queen amid the fallout from Harry and Meghan's Oprah Winfrey interview
It was a stretch to think corporate America would give up on the party that has their backs on taxes and regulation.
The Mavericks star gave his honest assessment of the league's revised playoff format for this season.
American Water Works Company, Inc. (NYSE: AWK) announced today that it intends to release its 2021 first quarter financial results after the market closes on Monday, May 3, 2021.
A gauge of global shares rose to record highs on Tuesday, led by surging technology-related stocks, as Treasury bond yields eased after U.S. consumer price data for March showed the pace of inflation was not rising wildly. The consumer price index rose 0.6%, the biggest gain since August 2012, as increased vaccinations and fiscal stimulus unleashed pent-up demand. "Fed comments continue to be conciliatory."
Shareholder rights law firm Robbins LLP announces that a purchaser of 3D Systems Corp. (NYSE: DDD) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between May 6, 2020 and March 1, 2021. 3D Systems provides comprehensive 3D printing and digital manufacturing services and digital design tools.
England allrounder Ben Stokes will miss the rest of the Indian Premier League after breaking a finger playing for Rajasthan Royals in their opening match against Punjab Kings. “He will stay with the Royals and support the rest of the group in the upcoming matches,” the team said Tuesday. Stokes was seen shaking his left hand after completing a catch in the deep to dismiss opener Chris Gayle in the 10th over of Monday's game.
"It's just got an incredible attention to detail, and it's well-crafted the whole way through."
Six cases of the rare blood clots cerebral venous sinus thrombosis are being investigated.
Images shared online show just how big some of the hailstones were.
JOHANNESBURG — South Africa suspended giving Johnson & Johnson vaccine shots Tuesday as a “precautionary measure” and the company delayed its European vaccine rollout following an FDA decision to pause the jabs while very rare blood clot cases are examined. South Africa has given more than 289,000 doses of the J&J vaccine to the country’s health workers without any reports of rare blood clots, Health Minister Dr. Zweli Mkhize told reporters. He said South Africa was halting the use of J&J jabs “out of an abundance of caution” and expected that questions over the J&J vaccine should “be cleared within a matter of days.” Mkhize said “in the unlikely event” that the J&J vaccines are permanently halted, South Africa would continue with its vaccination campaign in May using doses from Pfizer-BioNTech. Earlier, Johnson & Johnson said it was delaying the rollout of its coronavirus vaccine across Europe amid the U.S. probe, a move that experts worried could further shake vaccine confidence and complicate worldwide COVID-19 immunization efforts. The announcement came after regulators in the United States said they were recommending a “pause” in the single-dose shot to investigate reports of rare but potentially dangerous blood clots. “We have made the decision to proactively delay the rollout of our vaccine in Europe,” Johnson & Johnson said. The delay is a further blow to vaccination efforts in the European Union, which have been plagued by supply shortages, logistical problems and concerns over unusual blood clots in a small number of people who received the AstraZeneca vaccine. The blood clot reports prompted several countries in the 27-nation bloc to limit the AstraZeneca vaccine to older people. The bloc's drug regulator, the European Medicines Agency, has authorized the AstraZeneca shot for all people 18 and over. Both the J&J and AstraZeneca vaccines use a cold virus, called an adenovirus, to carry the coronavirus' spike gene into the body, prompting an immune response. Johnson & Johnson uses a human adenovirus to create its vaccine, while AstraZeneca uses a chimpanzee version. In a statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating six cases of unusual clots, including one death, that occurred six to 13 days after vaccination with the J&J shot. The FDA commissioner said she expected the pause to last a matter of days. The European Medicines Agency said it is “currently not clear” whether the J&J shot caused the rare clotting disorders. Last week, the EU drug regulator said it found a “possible link” between the AstraZeneca shot and rare blood clots but said the benefits of vaccination far outweighed the risks of COVID-19. It noted the risk of such clots is less than the blood clot risk that healthy women face from birth control pills. Dr. Adam Finn, a professor of pediatrics at Britain's University of Bristol, said it was possible the way the J&J and AstraZeneca vaccines were made may have contributed to the unusual clotting disorders in a very small proportion of people. “This may help give us a clue towards understanding the mechanism or a way to prevent this problem from occurring,” Finn said. "Investigation of this phenomenon is now an extremely urgent international priority.” European regulators o n March 11 endorsed the Johnson & Johnson vaccine for use in the EU, but the first supplies are only now arriving. The EU ordered 200 million doses of the Johnson & Johnson in 2021. Britain ordered 30 million doses of the J& J vaccine, but has yet to authorize its use. France had expected to receive 200,000 doses of the vaccine this week and was planning to start administering them next week to people aged 55 and over. In Croatia, where one in four people have already refused to receive the AstraZeneca vaccine, the state health service said “panicky and hasty regulatory reactions should be avoided.” The first of 900,000 J&J vaccines were to arrive Wednesday. The head of Italy’s National Health Institute, Silvio Brusaferro, said it was too early to say how the J&J slowdown will affect immunization plans, as the first deliveries of 180,000 doses arrived Tuesday. Officials in Germany, which was due to receive 232,800 J&J doses this week and 10.1 million doses by the end of June, said Tuesday there was no immediate change in plans.. “In principle, we naturally always take such warnings in an international context seriously and investigate them,” Health Ministry spokesman, Hanno Kautz, told reporters in Berlin. Spain was expecting 300,000 doses of J&J on Wednesday. Spanish Prime Minister Pedro Sánchez said the benefits of taking the vaccine remain greater than the risks but that more information is needed. In February, South Africa began vaccinating health workers with the J&J vaccine in a research trial after abandoning plans to use the AstraZeneca shot when a preliminary study suggested the AstraZeneca vaccine was only minimally effective against the variant of COVID-19 that first arose in the country. Last month, the African Union announced it signed a deal to buy up to 400 million doses of the J&J vaccine. Johnson & Johnson also has a deal to supply up to 500 million doses to the U.N.-backed COVAX initiative that helps get vaccines to the world's poor. Any concerns about the J&J vaccine would be another unwelcome complication for COVAX and for the billions of people in developing countries depending on the program. COVAX recently was hit by supply issues after its biggest supplier, the Serum Institute of India, announced it would delay exports of the AstraZeneca vaccine for several months due to a surge of cases on the subcontinent. ___ Jordans reported from Berlin and Cheng from London. Mike Corder in The Hague, Colleen Barry in Milan, Aritz Parra in Madrid, Dusan Stojanovic in Belgrade, Serbia, Mogomotsi Magome in Johannesburg and Sylvie Corbet in Paris contributed to this report. Frank Jordans, Maria Cheng And Andrew Meldrum, The Associated Press
Letting patients access mifepristone through telemedicine does not appear to pose any safety risks, the acting FDA commissioner said.
Only a few programs are expected to compete for a title most years. South Carolina is one of them.
Pool floats sold out like mad in 2020. Here are 15 of our favorite pool floats from brands like Funboy, ban.do, and more.
"We empathize with the pain that Black mothers, fathers, and children are feeling after yet another senseless tragedy," the former president said
Barack and Michelle Obama call for a 'full and transparent investigation' in statement issued Tuesday on the death of Daunte Wright.
The supermarket group will make the announcement of Garnier's appointment on Wednesday when it reports its full-year results, Sky News reported https://bit.ly/3uMV5W6. Both, Tesco and Kingfisher, which owns B&Q and Screwfix in the UK and Castorama and Brico Depot in France and other markets, declined to comment.
Multiple billboards supporting Morgan Wallen appeared in Nashville this week ahead of Sunday's Academy of Country Music Awards. The 27-year-old singer, one of country music's hottest rising stars, was deemed ineligible for the 56th ceremony after he was caught on video using the N-word.
Tan France says he "cannot wait to hold this baby, and to show him so much love"
SAO PAULO — Chinese pharmaceutical company Sinovac will donate 50,000 doses of its COVID-19 vaccine to South American soccer confederation CONMEBOL in a bid to protect players for upcoming tournaments. CONMEBOL announced Tuesday that the jabs will be used to inoculate players ahead of the Copa America in June and for other regional tournaments. “This is a huge step forward to beat the COVID-19 pandemic, but it doesn’t mean that we will in any way relax,” CONMEBOL president Alejandro Domínguez said in a statement. The soccer body said it is the first confederation to obtain a vaccine for widespread immunization, but it gave no details about who will get the vaccines and when. Uruguay President Luis Lacalle Pou, who worked as mediator, “was crucial for the completion of a deal of great importance for South American soccer," CONMEBOL said. Domínguez thanked Sinovac “for understanding that soccer is a fundamental activity for the economy, the culture, and the physical and mental health of South Americans.” However, Chinese officials have said they're looking for ways to boost the effectiveness of coronavirus vaccines. South America is now the epicenter of the pandemic with cases, hospitalizations and deaths on the rise. Brazil's death toll, second only to the United States', is quickly approaching 360,000. The country's seven-day average number of deaths hit a new record on Monday at 3,124. Several state championships were suspended in Brazil because of the collapse of the health care system. Other countries in the region are also experiencing a rise of the disease, which many health analysts have blamed on a potentially more contagious variant coming from Brazil. “We will keep our work responsibly, which allowed us to finish our tournaments without setbacks and without changing their formats," Dominguez said, in a reference to the last season. This year's Copa America, taking place in Argentina and Colombia, will be played between June 13 and July 10. The Copa Libertadores is already underway. ___ More AP soccer: https://apnews.com/hub/soccer and https://twitter.com/AP_Sports Mauricio Savarese, The Associated Press
NEW YORK, April 13, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Canoo Inc., ("Canoo" or the "Company") (NASDAQ: GOEV) from August 18, 2020 through March 29, 2021 (the "Class Period"). The lawsuit filed in the United States District Court for the Central District of California alleges violations of the Securities Exchange Act of 1934. If you purchased Canoo securities, and/or would like to discuss your legal rights and options please visit Canoo Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com The complaint alleges that during the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that: (i) an engineering services segment, (ii) the sales of subscriptions to vehicles to consumers, and (iii) the sale of vehicles to other businesses. The complaint alleges that, on March 29, 2021, the Company revealed that it was radically changing its business model by deemphasizing its engineering services business and by no longer focusing on its subscription-based business. On March 29, 2021, after the markets closed, Canoo issued a press release (“Q4 Release”) reporting its fourth quarter and full year 2020 results. The Q4 Release removed the language touting its “unique business model” simply stating: “Canoo has developed breakthrough electric vehicles that are reinventing the automotive landscape with bold innovations in design and pioneering technologies.” On the same day the Company held a conference call to discuss its financial results (the “Q4 Call”). During the call Defendant Aquila announced that Defendant Balciunas was being replaced as CFO. The Company’s CEO, Defendant Kranz was not on the call. During the Q4 Call Defendant Aquila revealed that “it was decided by our Board to de-emphasize the originally stated contract engineering services line.” In response to this news, shares of Canoo fell $2.50 (or 21.2%) from a March 29, 2021 close of $11.80 per share to close at $9.30 per share on March 30, 2021, on heavy volume. If you wish to serve as lead plaintiff, you must move the Court no later than June 1, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery does not require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member. If you purchased Canoo securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/canooinc-goev-shareholder-class-action-lawsuit-stock-fraud-386/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years. ATTORNEY ADVERTISING. © 2021 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter. Contact Information Matthew E. GuarneroBernstein Liebhard LLP https://www.bernlieb.com (877) 779-1414MGuarnero@bernlieb.com